Skip to main content
. 2017 May 8;8(32):52960–52974. doi: 10.18632/oncotarget.17674

Figure 6. MTT assay growth curves for A549 cells in the blank, vector control, TUSC3, TUSC3 siRNA, and TUSC3 + XAV939 groups.

Figure 6

A reduction in the growth of TUSC3 over-expressing ells was observed 3 days post-transfection. *, P < 0.05 compared to the blank and vector control groups; TUSC3, tumor suppressor candidate 3.